Shots: Medtronic enrolls the first patient in the ALLEVIATE-HF clinical trial assessing the ability of its Reveal LINQ ICM in identifying patients at high risk of worsening HF. The study […]readmore
Tags : Worsening
Shots: The approval is based on P-III SHIFT study trial assessing Corlanor vs PBO +SoC in 6500+ patients with reduced left ventricular function (LVEF ≤35%) and heart rate ≥70 bpm, […]readmore